LTRN
insider transactionsLantern Pharma Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $200.0K.
Net shares · 365d
+194.2K
194.2K buy · 0 sell
Net value · 365d
$200.0K
$200.0K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
4
194.2K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Buy·P
Director
$0
48.5K sh
Own New
-
Buy·P
Director
$100.0K
48.5K sh · $2.06
Own New
-
Buy·P
Director
$0
48.5K sh
Own New
-
Buy·P
Director
$100.0K
48.5K sh · $2.06
Own +106%
-
Grant·A
Director
$0
53.8K sh · 2 lots
Own New
-
Grant·A
Director
$0
42.3K sh · 2 lots
Own New
-
Grant·A
Director
$0
46.2K sh · 2 lots
Own New
-
Grant·A
Director
$0
42.3K sh · 2 lots
Own New
-
Grant·A
Director
$0
43.5K sh · 2 lots
Own New
-
Grant·A
Chief Financial Officer
$0
20.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
10.0K sh
Own New
-
Grant·A
Director
$0
5.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | Schalop Lee Troy | Buy P | 48.5K | $0 |
| May 12, 2026 | Schalop Lee Troy | Buy P | 48.5K | $100.0K |
| May 12, 2026 | KEYSER D JEFFREY | Buy P | 48.5K | $0 |
| May 12, 2026 | KEYSER D JEFFREY | Buy P | 48.5K | $100.0K |
| Jan 9, 2026 | KEYSER D JEFFREY | Grant A | 53.8K2 lots | $0 |
| Jan 9, 2026 | Chandru Vijay | Grant A | 42.3K2 lots | $0 |
| Jan 9, 2026 | Maccecchini Maria-Luisa | Grant A | 46.2K2 lots | $0 |
| Jan 9, 2026 | Silberstein David S. | Grant A | 42.3K2 lots | $0 |
| Jan 9, 2026 | Schalop Lee Troy | Grant A | 43.5K2 lots | $0 |
| Dec 18, 2025 | Margrave David R. KEY | Grant A | 20.0K | $0 |
| Dec 18, 2025 | Bhatia Kishor G. | Grant A | 10.0K | $0 |
| Aug 19, 2025 | Schalop Lee Troy | Grant A | 5.0K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About LTRN insider trading
This page tracks insider transactions for Lantern Pharma Inc. (LTRN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.